Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 489 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ophthalmic Surgery Clear all

Conditions: Glaucoma, Cataract
Interventions: Dexamethasone Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp; Drug
Lead sponsor: The New York Eye Surgery Center; Other
Eligibility: 21 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Retinal Detachment
Interventions: Triamcinolone Acetonide 40mg/mL; Drug
Lead sponsor: Virginia Polytechnic Institute and State University; Other
Eligibility: 19 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Ophthalmic Surgery
Interventions: Zymar; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Stanford, California

Conditions: Intraocular Melanoma, Melanoma (Skin)
Interventions: MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant, recombinant interleukin-12, sargramostim, tyrosinase peptide, alum adjuvant, adjuvant therapy; Biological · Drug · Procedure
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cataract, Refractive Errors
Interventions: PanOptix Trifocal Intraocular Lens; Device
Lead sponsor: Parkhurst NuVision Clinical Research LLC; Other
Eligibility: 22 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Cataract, Refractive Error, Low Vision
Interventions: Visual impairment intervention program; Procedure
Lead sponsor: Johns Hopkins University; Other
Eligibility: 65 Years and older
Enrollment: 2,544 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2002
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cataract
Interventions: Dexycu, Standard of Care post operative eye drops (steroid, antibiotic, NSAID); Drug
Lead sponsor: The Eye Institute of West Florida; Other
Eligibility: 40 Years to 90 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Largo, Florida

Conditions: Post Surgical Ocular Inflammation
Interventions: TRS01 eye drops, Placebo eye drops; Drug
Lead sponsor: Tarsier Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 5
States / cities: Inglewood, California • Petaluma, California • Washington, Missouri + 2 more

Conditions: Cataract, Astigmatism
Interventions: LaserArc; Other
Lead sponsor: Research Insight LLC; Industry
Eligibility: 22 Years and older
Enrollment: 50 participants
Timeline: 2022
U.S. locations: 1
States / cities: Belleville, Illinois

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Iris Melanoma, Metastatic Intraocular Melanoma, Recurrent Intraocular Melanoma, Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
Interventions: ziv-aflibercept, pharmacological study; Biological · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Duarte, California

Conditions: Retinal Detachment
Interventions: Dexmedetomidine infusion, propofol; Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 70 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Newark, New Jersey

Conditions: Image, Body
Interventions: Optical Coherence Tomography (OCT), Magnetic resonance imaging (MRI); Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Aphakia, Cataract
Interventions: enVista; Device
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Aliso Viejo, California

Conditions: Blepharoptosis, Ptosis, Eyelid, Myasthenia Gravis, Stroke, Traumatic Brain Injury, Chronic Progressive External Ophthalmoplegia
Interventions: Magnetic Levator Prosthesis (MLP), Kinesiotape Frontalis Sling (KTFS); Device
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 5 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Open Angle Glaucoma
Interventions: Combined cataract surgery with Hydrus microstent, Combined cataract surgery with iStent Inject W; Device
Lead sponsor: Diablo Eye Associates; Industry
Eligibility: 60 Years and older
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Walnut Creek, California

Conditions: Primary Open-angle Glaucoma
Interventions: iStent inject, Cataract surgery; Device · Procedure
Lead sponsor: Glaukos Corporation; Industry
Eligibility: 45 Years and older
Enrollment: 505 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Racine, Wisconsin

Conditions: Cataracts
Interventions: DisCoVisc, DuoVisc, BioVisc, Healon5, Amvisc Plus; Device
Lead sponsor: Alcon Research; Industry
Eligibility: 49 Years and older
Enrollment: 173 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2007
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Cataract
Interventions: Clareon TruPlus; Device
Lead sponsor: OVO LASIK + Lens; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Saint Louis Park, Minnesota

Conditions: Fuchs Dystrophy, Corneal Edema
Interventions: Corneal transplantation; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Dry Eye, Ocular Surface Disease, Cataract Surgery, Eyes Dry Feeling of
Interventions: Lacrifill, Saline; Drug
Lead sponsor: Eye Research Associates, LLC; Other
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Pittsburg, Kansas • Kansas City, Missouri

Conditions: Congenital Heart Disease
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Glaucoma, Glaucoma, Open Angle
Interventions: SOLX Titanium Sapphire Laser (TiSaLT), Argon Laser Trabeculoplasty (ALT); Device
Lead sponsor: SOLX, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 5
States / cities: Petaluma, California • Tampa, Florida • New York, New York + 2 more

Conditions: Inflammation, Pain, Cataract
Interventions: RX-10045; Drug
Lead sponsor: A.T. Resolve SARL; Industry
Eligibility: 18 Years and older
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Murray Hill, New Jersey

Conditions: Cataract, Inflammation, Surgery
Interventions: Mapracorat, Vehicle; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Rochester, New York

Search by objective public record fields.

Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery

Using Triamcinolone Acetonide to Reduce Pain After Scleral Buckle Surgery

One Hour Preoperative Gatifloxacin

Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma

Panoptix Trifocal Lens in Post Refractive Myopic Laser Vision Correction Surgery

A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents

"A Prospective Study of the Efficacy of Intracameral Dexamethasone (Dexycu™) Compared to Standard of Care Treatment for Post-Cataract Surgical Pain and Anterior Chamber Inflammation"

A Study of TRS01 in Participants With Post-surgical Ocular Inflammation

Evaluation of the Accuracy & Safety of the LaserArcs Nomogram

VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Dexmedetomidine Versus Propofol in Vitreoretinal Surgery

Whole Eye Optical Coherence Tomography (OCT) to Improve Refractive Surgery and Eye Care

One-Piece Hydrophobic Acrylic Intraocular Lens in Subjects Undergoing Cataract Extraction

Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis

Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma

Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery

DisCoVisc Comparative Evaluation

Visual and Patient Reported Outcomes With Clareon TruPlus

A Comparison Between Full Thickness and Partial Thickness Corneal Transplantation for Corneal Edema

Evaluation of Lacrifill

Ocular and Vision Problems in Patients After Fontan Operation

SOLX Titanium Sapphire Laser for Trabeculoplasty

Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery